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Abstract 
Review on Chordoma, with data on clinics, and the 
genes involved. 
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Identity 
Chordoma is a malignant tumour derived from 
remnants of the fetal notochord; it occurs along the 
spinal axis, predominantly in the sphenooccipital 
(35%), vertebral (15%) and sacrococcygeal (50%) 
regions 
Phylum 
Bones:Notochordal tumors:Chordoma 
Clinics and pathology 
Etiology 
Although most chordomas are sporadics, five 
families with chordoma occurrence have been 
reported, two of them displaying an autosomal 
dominant transmission with incomplete penetrance 
(MIM. *215400). 
Epidemiology 
Chordomas accounts for 1-4% of all primary bone 
tumours; the sacrococcygeal lesions are more 
common in the fifth decade of life, whereas the 
sphenooccipital tumours occur predominantly in 
children. 
Clinics 
Chordoma is a slowly-growing tumour, 
characterized by local destruction of bone and rarely 
distant metastatic spread. 
The differential diagnosis includes renal tumours, 
chondrosarcomas and myxopapillary ependymoma. 
Pathology 
Microscopically, it resembles normal fetal notochord 
in its different stages of development; it is composed 
of extremely large cells (known as physaliferous) 
and other small tumour cells; areas of cartilage and 
bone may be present. 
Dedifferentiated chordoma is a biphasic tumor, with 
features of a chordoma NOS and an abrupt transition 
to a high grade undifferentiated spindle cell tumor. 
Chordomas express keratins and brachyury is a 
highly specific marker for chordoma and helps to 
distinguish chordoma from chondrosarcoma and 
clear cell renal cell carcinoma. Brachyury as well as 
keratins are not expressed in a dedifferentiated 
component. 
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Cytogenetics Morphological 
The most common cytogenetic abnormality in 
chordoma is monosomy of chromosome 1 and gain 
of chromosome 7. 
Genes involved and 
proteins 
Note 
Approximately 70% of chordomas harbour either 
homozygous or heterozygous loss of CDKN2A and 
CDKN2B. Additional copy-number gain of 
brachyury (gene: T (T Brachyury Transcription 
Factor)) on chromosome locus 7q33 are commonly 
found in chordomas. In the coding region of 
brachyury somatic mutations have been found as 
well. Hotspot mutations in the tyrosine kinase 
receptor gene EGFR and in KRAS, NRAS, HRAS, 
BRAF are also described in chordomas. 
Furthermore, deletions and point mutations in 
SMARCB1 gene can be found. 
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